secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2026-03-05T23:59:59+00:00
Accession:  0001493152-26-008994
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa raises $1M via convertible notes and warrants for working capital
-------------------------------------------------------------------------

- Issued $1M aggregate principal 10% convertible promissory notes, maturing in 12 months, with a $0.02 floor price on conversion.
- Notes convertible at 80% of the lowest daily VWAP during the 10 trading days prior to conversion notice.
- Series A-4 warrants exercisable six months post-issuance, expiring in 5 years; exercise price linked to qualified offering or VWAP.
- Proceeds to be used for working capital; obligations guaranteed by subsidiary ZyVersa Therapeutics Operating, Inc.
- Securities sold to accredited investors in a private placement under Section 4(a)(2) and Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315226008994/0001493152-26-008994-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315226008994/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008994

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer